10x Genomics CFO Justin McAnear Will Resign Effective Aug 30, Adam Taich Appointed CFO Since Aug 12.
Portfolio Pulse from Benzinga Newsdesk
10x Genomics (NASDAQ:TXG) announced several executive changes. Justin McAnear will resign as CFO effective August 30, and Adam Taich has been appointed as the new CFO effective August 12. Additionally, Mennah Moustafa has been named Chief Commercial Officer effective August 1.

August 08, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
10x Genomics announced that CFO Justin McAnear will resign effective August 30, and Adam Taich will take over as CFO effective August 12. Mennah Moustafa has been named Chief Commercial Officer effective August 1.
The resignation of the CFO and the appointment of a new CFO and Chief Commercial Officer are significant changes for 10x Genomics. However, the impact on the stock price in the short term is uncertain as it depends on market perception of the new executives' capabilities.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100